blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3313529

EP3313529 - FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.03.2021
Database last updated on 03.10.2024
FormerExamination is in progress
Status updated on  28.08.2019
FormerRequest for examination was made
Status updated on  30.03.2018
FormerThe international publication has been made
Status updated on  30.12.2016
Most recent event   Tooltip19.03.2021Application deemed to be withdrawnpublished on 21.04.2021  [2021/16]
Applicant(s)For all designated states
Dana Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, Massachusetts 02215 / US
[2018/18]
Inventor(s)01 / GRAY, Nathanael, S.
26 Greenview Avenue
Boston, MA 02130 / US
02 / ZHANG, Tinghu
118 Franklin Street Apt. 2
Brookline, MA 02445 / US
 [2018/18]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2018/18]HGF Limited
4th Floor
Merchant Exchange
17-19 Whitworth Street West
Manchester M1 5WG / GB
Application number, filing date16815397.124.06.2016
[2018/18]
WO2016US39302
Priority number, dateUS201562185366P26.06.2015         Original published format: US 201562185366 P
[2018/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016210291
Date:29.12.2016
Language:EN
[2016/52]
Type: A1 Application with search report 
No.:EP3313529
Date:02.05.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 29.12.2016 takes the place of the publication of the European patent application.
[2018/18]
Search report(s)International search report - published on:US29.12.2016
(Supplementary) European search report - dispatched on:EP22.11.2018
ClassificationIPC:A61P35/02, C07D401/14, A61K31/506
[2018/18]
CPC:
A61K31/519 (EP,US); A61K31/166 (EP,US); A61K31/167 (EP,US);
A61K31/34 (EP,US); A61K31/381 (EP,US); A61K31/437 (EP,US);
A61K45/06 (EP,US); A61P35/02 (EP,US); C07D491/048 (EP,US);
C07D495/04 (EP,US); C07D519/00 (EP,US) (-)
C-Set:
A61K31/437, A61K2300/00 (US,EP);
A61K31/519, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/18]
TitleGerman:KONDENSIERTE BICYCLISCHE PYRIMIDINDERIVATE UND VERWENDUNGEN DAVON[2018/18]
English:FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND USES THEREOF[2018/18]
French:DÉRIVÉS DE PYRIMIDINE BICYCLIQUES FUSIONNÉS ET LEURS UTILISATIONS[2018/18]
Entry into regional phase25.01.2018National basic fee paid 
25.01.2018Search fee paid 
25.01.2018Designation fee(s) paid 
25.01.2018Examination fee paid 
Examination procedure25.01.2018Examination requested  [2018/18]
25.01.2018Date on which the examining division has become responsible
20.06.2019Amendment by applicant (claims and/or description)
02.09.2019Despatch of a communication from the examining division (Time limit: M06)
12.03.2020Reply to a communication from the examining division
09.07.2020Despatch of a communication from the examining division (Time limit: M04)
20.11.2020Application deemed to be withdrawn, date of legal effect  [2021/16]
10.12.2020Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2021/16]
Fees paidRenewal fee
27.06.2018Renewal fee patent year 03
27.06.2019Renewal fee patent year 04
29.06.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]CN103242341  (GUANGZHOU INST BIOMED & HEALTH) [I] 1-16* paragraphs [[0410]] , [ [0517]]; claim - *;
 [XI]CN104177363  (JIANGSU SIMCERE PHARMACEUTICAL, et al) [X] 1,2 * paragraphs [[374]] , [ [389]] , [ [464]]; claim -; compounds 27e, 28e, 38d * [I] 3-16
International search[Y]US2013040949  (GRAY NATHANAEL S [US], et al) [Y] 1-11, 12/1-11, 13/12/1-11,14/12/1-11, 15/12/1-11, 16/15/12/1-11, 17/12/1-11,18/12/1-11, 19/12/1-11, 20/19/12/1-11, 21/12/1-11, 22/12/1-11, 23/22/12/1-11, 24/12/1-11, 25/1-11, 26/25/1-11, 27/25/1-11, 2* ; paragraphs [0011], [0013]-[0016], [0019]-[0021], [0023], [0033], [0069], [0077], [0091] *;
 [Y]WO2015058140  (DANA FARBER CANCER INST INC [US]) [Y] 1-11, 12/1-11, 13/12/1-11, 14/12/1-11, 15/12/1-11, 16/15/12/1-11, 17/12/1-11, 18/12/1-11, 19/12/1-11, 20/19/12/1-11, 21/12/1-11, 22/12/1-11, 23/22/12/1-11, 24/12/1-11, 25/1-11, 26/25/1-11, 27/25/1-11, * ; paragraphs [0031], [0041], [0095] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.